Mohty, Mohamad
Dulery, Remy
Gauthier, Jordan http://orcid.org/0000-0002-5769-8409
Malard, Florent http://orcid.org/0000-0002-3474-0002
Brissot, Eolia
Aljurf, Mahmoud
Bazarbachi, Ali
Chabanon, Christian http://orcid.org/0000-0002-3755-4889
Kharfan-Dabaja, Mohamed A. http://orcid.org/0000-0001-7394-5185
Savani, Bipin N.
Huang, He
Kenderian, Saad S.
Perales, Miguel-Angel
Yakoub-Agha, Ibrahim
Nagler, Arnon
Article History
Received: 10 March 2020
Revised: 26 March 2020
Accepted: 27 March 2020
First Online: 18 April 2020
Compliance with ethical standards
:
: MM reports grants and/or lecture honoraria from Janssen, Sanofi, Maat Pharma, JAZZ pharmaceutical, Celgene, Amgen, BMS, Takeda, Pfizer, and Roche, all outside the submitted work. FM reports lecture honoraria from Therakos/Mallinckrodt, Biocodex, Janssen, Keocyte, Sanofi, JAZZ pharmaceutical and Astellas, all outside the submitted work. AB reports honoraria from Abbvie, Novartis, Takeda, Roche, Celgene, Pfizer, Janssen and Amgen and Research support from Novartis, Takeda, Roche, Celgene and Janssen. CC reports honoraria from Kite/Gilead and Novartis. SSK is inventor on patents and royalties licensed to Novartis, Humanigen, and Mettaforge. He receives research support from Kite, Gilead, Novartis, Juno, Celgene, Humanigen, Tolero, Lentigen, Sunesis, and Morphosys. He has served on SAB for Humanigen, Kite, and Juno. M-AP reports honoraria from Abbvie, Bellicum, Bristol-Myers Squibb, Celgene, Incyte, Merck, Novartis, Nektar Therapeutics, Omeros, and Takeda. He serves on DSMBs for Servier and Medigene, and the scientific advisory boards of MolMed and NexImmune. He has received research support for clinical trials from Incyte, Kite (Gilead) and Miltenyi. IY-A reports honorarium from Gilead/Kite, Celgene, Novartis and Jansse. The other authors did not disclose any relevant conflict of interest in relation to this work